Derma Pella Acne Wash For Oily Skin
NDC Package 82160-764-01
Package Information
Derma Pella Acne Wash For Oily Skin is non-irritating foaming cleanser formulated for acne-prone skins, helps gently exfoliate skin without over drying, deep cleans pores control excess oil, unclog pores and prevent new acne from forming. Marketed by Pella Pharmaceuticals Co. Ltd, this product is identified by NDC 82160-764 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 865105 - salicylic acid 0.5 % Medicated Liquid Soap
- RxCUI: 865105 - salicylic acid 5 MG/ML Medicated Liquid Soap
- RxCUI: 865105 - salicylic acid 0.5 % Foaming Cleanser
- RxCUI: 865105 - salicylic acid 0.5 % Mask
- RxCUI: 865105 - salicylic acid 0.5 % Topical Gel Cleanser
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82160 - Pella Pharmaceuticals Co. Ltd
- 82160-764 - Derma Pella Acne Wash For Oily Skin
- 82160-764-01 - 150 mL in 1 BOTTLE, PLASTIC
- 82160-764 - Derma Pella Acne Wash For Oily Skin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82160-764-01 identifies a specific commercial package of 150 ml in 1 bottle, plastic of Derma Pella Acne Wash For Oily Skin, labeled by Pella Pharmaceuticals Co. Ltd. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pella Pharmaceuticals Co. Ltd on May 16, 2023. The current certification is valid through December 31, 2026.
How is this Pella Pharmaceuticals Co. Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82160076401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.